ARTICLE | Company News
Applied Immune Sciences Inc., Duke University, Rhône-Poulenc Rorer Inc. gene/cell therapy news
November 13, 1995 8:00 AM UTC
ExVivo Therapies, a joint venture between AISX and RPR, began construction of the ExVT/Duke Cell Processing Center. The 20,000 square foot facility will house cell processing services for clinical tri...